IP Library Patent Application 17941623
Patent Application
App. No. 17/941,623

PLATFORM AND METHOD FOR TOKENIZING DNA DATA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/941,623
Abstract

A system, method, device, and data platform for managing DNA data utilizing tokens. DNA data associated with a user is obtained. The DNA data is stored in a DNA profile associated with the user by a data platform. The DNA data is tokenized into one or more tokens. The DNA data is monetized.

Claims (48)

1 . A method for managing deoxyribonucleic acid (DNA) data utilizing tokens, comprising:

obtaining DNA data associated with a user, the DNA data is stored in a DNA profile associated with the user by a data platform;

tokenizing the DNA data into one or more tokens; and

monetizing the DNA data.

2 . The method of claim 1 , further comprising:

generating each of the one or more tokens associated with the DNA data, wherein the one or more tokens are blockchain tokens saved in a digital ledger, and wherein the one or more tokens are linked to the associated DNA data that is securely stored.

3 . The method of claim 1 , further comprising:

sampling DNA from the user; and

processing the DNA to generating the DNA data.

4 . The method of claim 1 , further comprising:

analyzing the DNA data to determine at least types of data and amounts of data included within the DNA data.

5 . The method of claim 1 , further comprising:

valuing the DNA data;

determining potential monetization strategies for the DNA data; and

presenting the monetization strategies to the one or more corporations.

6 . The method of claim 1 , further comprising:

determining traits, defects, and risks for developing medical conditions.

7 . The method of claim 1 , wherein the monetization strategies include at least selling the DNA data, leasing the DNA data, and providing the DNA data without identifying information regarding individuals or corporations.

8 . The method of claim 1 , further comprising:

creating a smart contract controlling utilization of the DNA data if and when monetized.

9 . The method of claim 1 , further comprising:

deidentifying the DNA data so that the user is unidentifiable from the one or more tokens.

10 . The method of claim 1 , further comprising:

advertising the DNA data to authorized parties; and

performing transactions for the one or more tokens associated with the DNA data.

11 . A system for managing DNA data, comprising:

a DNA system for determining DNA data associated with a user;

a plurality of electronic devices executing a data application, the data application is configured to capture the information associated with a user; and

a data platform in communication with the DNA system and accessible by the plurality of electronic devices executing the data application through one or more networks, wherein the data platform tokenizes the DNA data and the information into one or more tokens, and monetizes the DNA data, wherein the DNA data is stored in a DNA profile associated with the user.

12 . The system of claim 11 , wherein the DNA system receives a DNA sample from the user, wherein the system includes a DNA sequencer.

13 . The system of claim 11 , wherein the information and the DNA data is deidentified so that the user is unidentifiable from the one or more tokens, wherein the one or more tokens are blockchain tokens, and wherein the one or more tokens and associated DNA data are saved in a digital ledger.

14 . The system of claim 11 , wherein the data platform further generates each of the one or more tokens associated with the DNA data, advertises the DNA data to authorized parties, and performs transactions for the one or more tokens associated with the DNA data.

15 . The system of claim 11 , wherein the data platform further determines traits, defects, and risks for developing medical conditions.

16 . A data platform, comprising:

a processor for executing a set of instructions;

a memory for storing the set of instructions, wherein the set of instructions are executed to:

determine information associated with a user;

obtain DNA data associated with a user, the information and the DNA data is stored in a DNA profile associated with the user by a data platform;

deidentifying the DNA profile so that the user is not identifiable through the information or the DNA data;

tokenize the DNA profile into one or more tokens; and

monetize the DNA data.

17 . The data platform of claim 16 , further comprising:

a DNA system that determines the DNA data from a DNA sample provided by the user.

18 . The data platform of claim 16 , wherein the set of instructions are further executed to:

analyze the DNA data to determine at least traits, defects, and risks for developing medical conditions.

19 . The data platform of claim 16 , wherein the set of instructions generate each of the one or more tokens associated with the DNA data, advertise the DNA data to authorized parties, and perform transactions for the one or more tokens associated with the DNA data, wherein the one or more tokens are blockchain tokens, and wherein the one or more tokens and associated DNA data are saved in a digital ledger.

20 . The data platform of claim 16 , further comprising:

a gene sequencer configured to generate the DNA data from a specimen of the user.

Assignments (3)
CHANGE OF NAME Recorded Mar 13, 2025
From: WISA TECHNOLOGIES, INC.
To: DATAVAULT AI INC.
Reel/Frame 070514/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2025
From: DATA VAULT HOLDINGS, INC.
To: WISA TECHNOLOGIES, INC.
Reel/Frame 069837/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2022
From: BRADLEY, NATHANIEL T.; BLAIKIE, ALFRED BLAIR, III; PAUGH, JOSHUA S.
To: DATA VAULT HOLDINGS, INC.
Reel/Frame 061470/0332 →